Paasa Logo
Daiichi Sankyo Company, Limited logo
4568JPXMarket closedOpens 9:00am JST

Daiichi Sankyo Company, Limited

¥2,784.50Last updated
+¥4.50 (0.16%)Past day
Timezone

Daiichi Sankyo Company, Limited (JPX: 4568) is trading at ¥2,784.50, about ₹1,700 at today's JPY/INR rate, as of 29 Sep 2026, 2:30 AM ET, up 0.16% today. Indian residents can buy Daiichi Sankyo from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:¥2,830.00
Previous close:¥2,780.00
Volume:6.53M

Today's low

¥2,769.00

Today's high

¥2,848.00

52 week low

¥2,390.00

52 week high

¥4,178.00

4568 opened at ¥2,830.00, closed previously at ¥2,780.00, and has traded between ¥2,390.00 and ¥4,178.00 over the past 52 weeks.

About

Daiichi Sankyo Company, Limited is a global pharmaceutical enterprise actively involved in the research, development, manufacturing, importation, marketing, and distribution of a diverse array of medicinal products worldwide. Its extensive product lineup addresses numerous therapeutic areas. In oncology, key offerings include trastuzumab deruxtecan, an anti-HER2 antibody drug conjugate, alongside treatments like Gefitinib for malignant tumors, Bicalutamide for prostate cancer, and Tamoxifen, an anti-breast cancer agent. For pain management, the company provides mirogabalin and loxoprofen (an anti-inflammatory analgesic). Diabetes treatments feature teneligliptin/canagliflozin and teneligliptin, with colesevelam serving dual purposes for hypercholesterolemia and type 2 diabetes. Other notable prescription drugs include lacosamide (an anti-epileptic), prasugrel (an antiplatelet), denosumab (for osteoporosis and bone disorders), edoxaban (an anticoagulant), esomeprazole (for ulcer treatment), memantine (for Alzheimer's disease), and laninamivir (for influenza). The company also supplies olmesartan (an antihypertensive), levofloxacin (an antibacterial), pravastatin (for hypercholesterolemia), Silodosin (for dysuria), and ferric carboxymaltose/iron sucrose injections for anemia. Beyond prescription medications, Daiichi Sankyo markets popular consumer health brands such as Lulu (a combination cold remedy), Loxonin S (an antipyretic/anti-inflammatory painkiller), Transino (for melasma and skin improvement), Minon (skincare), and the oral care lines Breath Labo and Clean Dental. The company further contributes to public health with various vaccines, including adsorbed cell culture-derived influenza, influenza HA, measles-rubella combined, and mumps vaccines. Its operations also extend beyond human pharmaceuticals to include veterinary drugs, cosmetics, medical equipment, food products, drinking water, and the production of active pharmaceutical ingredients (APIs) and intermediates. Daiichi Sankyo is collaborating with Guardant Health on the development of Guardant360 CDx, a companion diagnostic for Enhertu, specifically for advanced metastatic non-small cell lung cancer. Founded in 1899, the company is headquartered in Tokyo, Japan.

Country
JP
CEO
Hiroyuki Okuzawa
Exchange listed on
JPX
Industry
Drug Manufacturers - General
Base currency
JPY
Full Time Employees
20,171
Sector
Healthcare
IPO date
28/09/2005

Key statistics

Avg. volume

6.78M

Market cap

¥5.07T

P/E Ratio

21.08

Price-to-sales ratio

2.28

Enterprise value

¥4.93T

Free cash flow yield

-0.05%

Debt-to-equity ratio

0.29

Return on equity

14.44%

ROIC

5.71%

Beta

0.80

Dividend yield

3.20%

Last dividend

¥78.00

Financial overview

Revenue

¥2.12T

Earnings per share

¥140.44

Free cash flow

-¥50.71B

Net profit margin

10.93%

Gross margin

68.47%

EBITDA

¥348.88B

Revenue growth

12.55%

Similar securities

This is not an investment recommendation

How to buy Daiichi Sankyo from India

Indian residents can buy Daiichi Sankyo shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.

  3. Search for Daiichi Sankyo and place an order

    Find Daiichi Sankyo by name or by its ticker, 4568, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. Daiichi Sankyo trades 5:30 am – 12:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Daiichi Sankyo position in JPY and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.

Read the full guide: how to invest in Daiichi Sankyo from India

Trading and taxes when buying Daiichi Sankyo from India

Trading and limits

Trading hours
9:00 am – 3:30 pm JST
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Daiichi Sankyo’s current yield is 3.20%.Dividend tax explained
Estate or inheritance tax
May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Daiichi Sankyo stock?

Yes. Daiichi Sankyo (4568) has been listed on the Tokyo Stock Exchange since 2005, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Daiichi Sankyo share cost in rupees?

One Daiichi Sankyo share is ¥2,784.50 — about ₹1,700 at a JPY/INR rate of 0.6107 on 28 Sep 2026. Both the Daiichi Sankyo price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Daiichi Sankyo from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

What is the minimum I can buy of Daiichi Sankyo?

The Tokyo Stock Exchange typically trades in units of 100 shares.

How are gains on Daiichi Sankyo shares taxed in India?

Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the Daiichi Sankyo price. Paasa issues a capital-gains statement for your return.

Does Daiichi Sankyo pay a dividend, and how is it taxed in India?

Yes. Daiichi Sankyo pays a dividend and the current yield is 3.20%; the last declared dividend was ¥78.00 per share, about ₹47.63. Dividends are taxed at your slab rate in India. Japan withholds a preferential 10% on dividends for Indian residents under the India–Japan DTAA rather than the higher domestic rate, and the tax withheld can be claimed as a foreign tax credit in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.

When can I trade Daiichi Sankyo from India?

The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.

Is there estate or inheritance tax on Daiichi Sankyo shares held from India?

Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.

Do I have to declare Daiichi Sankyo shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Daiichi Sankyo holding, its cost and its closing value.

How do I sell Daiichi Sankyo and bring the money back to India?

You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.